ArticleScientific reports2025
AOH induces oxidative stress and DNA damage in ovarian cancer cells via modulation of GPER1 and HIF1α/PI3K/CLDNs signaling pathway.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
Abstract
Claudins (CLDNs) are small proteins that form tight junctions (TJs) in cells and play a key role in various biological processes in cells. Previous results have shown that CLDNs expression can be regulated by hormones and, therefore, can also be regulated by compounds that mimic their action. Such compounds belong to a large group called endocrine-disrupting chemicals (EDCs). Alternariol (AOH), an emerging mycotoxin, contaminates various food products. AOH is reported to be genotoxic and to induce oxidative stress. Previous results showed that AOH is also estrogenic and acts as an androgen receptor (AR) agonist, suggesting that it might act as one of the EDCs, however, its detailed molecular mechanism has not been fully elucidated yet. In this study, we decided to evaluate the interplay between AOH and G protein-coupled estrogen receptor 1 (GPER1) in hormone-dependent human ovarian cancer (OC) cells with a focus on the involvement of hypoxia-inducible factor 1-alpha/phosphoinositide 3-kinases/protein kinase B (HIF1α/PI3K/Akt) and claudins (CLDNs) signaling pathways in that effect. We observed that AOH induces oxidative stress and DNA damage in OC cells, and this effect is partially mediated by GPER1. We found that the GPER1 antagonist G15 partially mitigated AOH-induced ROS production and significantly reduced DNA damage, confirming the receptor's role in mediating these effects. Furthermore, we observed the involvement of HIF1α/PI3K/Akt and CLDNs pathways in AOH effect in OC cells. In conclusion, we postulate that AOH has pro-oxidative ability and that this effect is partially mediated by GPER1. Moreover, we postulated that HIF1α/PI3K/Akt and CLDNs participate in AOH action in OC cells, which in turn provides useful information for future toxicological research studies as a new molecular mechanism of AOH.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.